Management of Cutaneously Exposed Carotid Stents in Recurrent and Unresectable Head and Neck Cancer

Abstract

Objective Carotid blowout syndrome (CBS) is a rare but potentially life-threatening complication of head and neck cancer (HNC) treatment. Patients with CBS are managed with covered stents, limited published information exists regarding the management of delayed complications, specifically cutaneous exposure of stents. Here, we present our experience managing cutaneously exposed carotid artery stents (CAS) in patients with recurrent and unresectable HNC.

Methods A single-institution retrospective analysis was performed to identify recurrent HNC patients who underwent CAS placement for CBS and complicated with cutaneous exposure of the stent between 2014 and 2016. Medical records were reviewed with attention to treatment history, pre-, intra-, and postoperative courses, anticoagulation needs, and durability of the reconstruction.

Results We identified three patients who presented with a right CAS fully exposed in a large, ulcerative wound. All patients underwent a right pectoralis major myocutaneous flap (PMMF) to cover the exposed stent within 30 days of presentation to our institution. Two of three patients attained adequate coverage of the stent for more than 30 days, while one experienced partial flap dehiscence within 12 days. Two patients developed postoperative chest hematomas, which were managed conservatively. Two of three patients were able to undergo further palliative adjuvant treatments within 60 days of the initial surgical procedure.

Conclusion In this small series, durable coverage of an exposed carotid artery with PMMF was successful in two of three patients with extensive disease burden and complex prior treatment history. No mortalities occurred within 30 days postoperatively.

Keywords

head and neck cancer - carotid artery stent - carotid blowout syndrome - pectoralis major myocutaneous flap - complication

Publikationsverlauf

Eingereicht: 27. März 2020

Angenommen: 25. Juli 2020

Artikel online veröffentlicht:
12. Oktober 2020

• References

• 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
• 2 Howlader N, Noone A, Krapcho M. et al, eds. SEER cancer statistics review, 1975–2013, National Cancer Institute. Accessed April 26, 2016 at: http://seer.cancer.gov/csr/1975_2013/
• 3 Gaba RC, West DL, Bui JT, Owens CA, Marden FA. Covered stent treatment of carotid blowout syndrome. Semin Intervent Radiol 2007; 24 (01) 47-52
• 4 Warren FM, Cohen JI, Nesbit GM, Barnwell SL, Wax MK, Andersen PE. Management of carotid ‘blowout’ with endovascular stent grafts. Laryngoscope 2002; 112 (03) 428-433
• 5 Powitzky R, Vasan N, Krempl G, Medina J. Carotid blowout in patients with head and neck cancer. Ann Otol Rhinol Laryngol 2010; 119 (07) 476-484
• 6 Shah H, Gemmete JJ, Chaudhary N, Pandey AS, Ansari SA. Acute life-threatening hemorrhage in patients with head and neck cancer presenting with carotid blowout syndrome: follow-up results after initial hemostasis with covered-stent placement. AJNR Am J Neuroradiol 2011; 32 (04) 743-747
• 7 McGettigan B, Parkes W, Gonsalves C, Eschelman D, Keane W, Boon MS. The use of a covered stent in carotid blowout syndrome. Ear Nose Throat J 2011; 90 (04) E17
• 8 Chang FC, Luo CB, Lirng JF. et al. Evaluation of the outcomes of endovascular management for patients with head and neck cancers and associated carotid blowout syndrome of the external carotid artery. Clin Radiol 2013; 68 (11) e561-e569
• 9 Gaynor BG, Haussen DC, Ambekar S, Peterson EC, Yavagal DR, Elhammady MS. Covered stents for the prevention and treatment of carotid blowout syndrome. Neurosurgery 2015; 77 (02) 164-167
• 10 Liang NL, Guedes BD, Duvvuri U. et al. Outcomes of interventions for carotid blowout syndrome in patients with head and neck cancer. J Vasc Surg 2016; 63 (06) 1525-1530
• 11 Chaloupka JC, Putman CM, Citardi MJ, Ross DA, Sasaki CT. Endovascular therapy for the carotid blowout syndrome in head and neck surgical patients: diagnostic and managerial considerations. AJNR Am J Neuroradiol 1996; 17 (05) 843-852
• 12 Roh JL, Suh DC, Kim MR. et al. Endovascular management of carotid blowout syndrome in patients with head and neck cancers. Oral Oncol 2008; 44 (09) 844-850
• 13 Farivar BS, Lee DH, Khalil A, Abrol S, Flores L. Carotid blowout syndrome: endovascular management of acute hemorrhage with tapering overlapped covered stents. Ann Vasc Surg 2014; 28 (08) 1934.e7-1934.e11
• 14 Haas RA, Ahn SH. Interventional management of head and neck emergencies: carotid blowout. Semin Intervent Radiol 2013; 30 (03) 245-248
• 15 Chang FC, Luo CB, Lirng JF. et al. Complications of carotid blowout syndrome in patients with head and neck cancers treated by covered stents. Interv Neuroradiol 2008; 14 (Suppl. 02) 29-33
• 16 Pyun HW, Lee DH, Yoo HM. et al. Placement of covered stents for carotid blowout in patients with head and neck cancer: follow-up results after rescue treatments. AJNR Am J Neuroradiol 2007; 28 (08) 1594-1598
• 17 Simental A, Johnson JT, Horowitz M. Delayed complications of endovascular stenting for carotid blowout. Am J Otolaryngol 2003; 24 (06) 417-419
• 18 Chaudhary N, Gemmete JJ, Thompson BG, Pandey AS. Intracranial endovascular balloon test occlusion-indications, methods, and predictive value. Neurosurg Clin N Am 2009; 20 (03) 369-375
• 19 Aničin A, Šifrer R, Strojan P. Pectoralis major myocutaneous flap in primary and salvage head and neck cancer surgery. J Oral Maxillofac Surg 2015; 73 (10) 2057-2064
• 20 O'Neill JP, Shine N, Eadie PA, Beausang E, Timon C. Free tissue transfer versus pedicled flap reconstruction of head and neck malignancy defects. Ir J Med Sci 2010; 179 (03) 337-343